A £15m Fund investing in early stage, revenue generating UK companies. We invest in high potential companies that are pursuing scalable market opportunities.
Focused on investments in digital health, B2B software, particularly in the Northeast US, and hard tech startups nationwide, aiming to partner with ambitious founders to build high-growth companies.
Connects U.S. and international investors with exclusive, high-yield opportunities in emerging and frontier markets, while also offering select institutional-grade deals across Europe and the U.S.
